Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
plusONE: Time-to-effect Cryoballoon Ablation for Paroxysmal AF
NCT02789358Completed
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by INCLIVA Biomedical Research Institute. Primary endpoint: Atrial fibrillation-free survival without antiarrhythmic drug therapy at 12 months. Started Dec 2015; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02789358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789358.